- Home
- KRMD vs VERU Comparison
KRMD vs VERU Comparison
Compare KRMD & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- VERU
- Stock Information
- Founded
- KRMD 1980
- VERU 1971
- Country
- KRMD United States
- VERU United States
- Employees
- KRMD N/A
- VERU N/A
- Industry
- KRMD Medical/Dental Instruments
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- VERU Health Care
- Exchange
- KRMD Nasdaq
- VERU Nasdaq
- Market Cap
- KRMD 127.0M
- VERU 113.1M
- IPO Year
- KRMD N/A
- VERU 1990
- Fundamental
- Price
- KRMD $2.73
- VERU $0.93
- Analyst Decision
- KRMD Strong Buy
- VERU Strong Buy
- Analyst Count
- KRMD 3
- VERU 4
- Target Price
- KRMD $3.33
- VERU $4.00
- AVG Volume (30 Days)
- KRMD 40.3K
- VERU 594.0K
- Earning Date
- KRMD 11-06-2024
- VERU 12-06-2024
- Dividend Yield
- KRMD N/A
- VERU N/A
- EPS Growth
- KRMD N/A
- VERU N/A
- EPS
- KRMD N/A
- VERU N/A
- Revenue
- KRMD $30,817,017.00
- VERU $14,091,909.00
- Revenue This Year
- KRMD $15.46
- VERU N/A
- Revenue Next Year
- KRMD $17.47
- VERU N/A
- P/E Ratio
- KRMD N/A
- VERU N/A
- Revenue Growth
- KRMD 4.70
- VERU N/A
- 52 Week Low
- KRMD $1.98
- VERU $0.36
- 52 Week High
- KRMD $3.09
- VERU $1.92
- Technical
- Relative Strength Index (RSI)
- KRMD 58.57
- VERU 64.34
- Support Level
- KRMD $2.42
- VERU $0.80
- Resistance Level
- KRMD $2.76
- VERU $0.94
- Average True Range (ATR)
- KRMD 0.14
- VERU 0.06
- MACD
- KRMD -0.00
- VERU 0.02
- Stochastic Oscillator
- KRMD 61.39
- VERU 75.20
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.